{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:39:40Z","timestamp":1791261580606,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"DOI":"10.1007\/s11904-025-00769-6","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:10:07Z","timestamp":1768176607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CRISPR Applications in HIV Management \u2013 Prevention,\u00a0Diagnosis, Monitoring and Treatment"],"prefix":"10.1007","volume":"23","author":[{"given":"B\u00e1rbara","family":"S. Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"V. Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"769_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1377\/hlthaff.2018.05391","volume":"38","author":"SS Forsythe","year":"2019","unstructured":"Forsythe SS, McGreevey W, Whiteside A, Shah M, Cohen J, Hecht R, et al. Twenty years of antiretroviral therapy for people living with hiv: global costs, health achievements, economic benefits. Health Aff. 2019;38:1163\u201372. https:\/\/doi.org\/10.1377\/hlthaff.2018.05391.","journal-title":"Health Aff"},{"key":"769_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/bcp.12403","volume":"79","author":"A Tseng","year":"2014","unstructured":"Tseng A, Seet J, Phillips EJ. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. Br J Clin Pharmacol. 2014;79:182\u201394. https:\/\/doi.org\/10.1111\/bcp.12403.","journal-title":"Br J Clin Pharmacol"},{"key":"769_CR3","unstructured":"Joint United Nations Programme on HIV\/AIDS, Global HIV. accessed November 28, & AIDS statistics \u2014 Fact sheet 2024. https:\/\/www.unaids.org\/en\/resources\/fact-sheet (2024)."},{"key":"769_CR4","unstructured":"World Health Organization. HIV statistics, globally and by WHO region. (2023)."},{"key":"769_CR5","unstructured":"World Health Organization. HIV and AIDS 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids (accessed March 3, 2024)."},{"key":"769_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/B978-0-12-814515-9.00042-4","volume-title":"Encyclopedia of Virology: Volume 1\u20135, Fourth Edition","author":"B Woodburn","year":"2020","unstructured":"Woodburn B, Emery A, Swanstrom R. Human Immunodeficiency Virus (Retroviridae). In: Encyclopedia of Virology: Volume 1\u20135, Fourth Edition, vol. 2. 2020. p. 460\u201374. https:\/\/doi.org\/10.1016\/B978-0-12-814515-9.00042-4."},{"key":"769_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101351","author":"SK Masenga","year":"2023","unstructured":"Masenga SK, Mweene BC, Luwaya E, Muchaili L, Chona M, Kirabo A. HIV\u2013host cell interactions. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12101351.","journal-title":"Cells"},{"key":"769_CR8","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.91","author":"JW Sleasman","year":"2003","unstructured":"Sleasman JW, Goodenow MM. HIV-1 infection. J Allergy Clin Immunol. 2003. https:\/\/doi.org\/10.1067\/mai.2003.91. 111.","journal-title":"J Allergy Clin Immunol"},{"key":"769_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101472","author":"RT Veenhuis","year":"2021","unstructured":"Veenhuis RT, Abreu CM, Shirk EN, Gama L, Clements JE. HIV replication and latency in monocytes and macrophages. Semin Immunol. 2021. https:\/\/doi.org\/10.1016\/j.smim.2021.101472.","journal-title":"Semin Immunol"},{"key":"769_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G H\u00fctter","year":"2009","unstructured":"H\u00fctter G, Nowak D, Mossner M, Ganepola S, M\u00fc\u00dfig A, Allers K, et al. Long-Term control of HIV by CCR5 Delta32\/Delta32 Stem-Cell transplantation. N Engl J Med. 2009;360:692\u2013700.","journal-title":"N Engl J Med"},{"key":"769_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118190","author":"P Mundlia","year":"2025","unstructured":"Mundlia P, Sharma A, Kaur J, Chaubey B, Ranawat P, Sood V, et al. From antiretrovirals to curative therapies: current developments in HIV treatment and prevention. Eur J Med Chem. 2025. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118190.","journal-title":"Eur J Med Chem"},{"key":"769_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2025.1634193","author":"J Clees","year":"2025","unstructured":"Clees J, Basic M, Cruz PE, Ramirez SH, Andrews AM. In pursuit of an HIV cure: from stem cell transplants to gene therapies. Front Genome Ed. 2025. https:\/\/doi.org\/10.3389\/fgeed.2025.1634193.","journal-title":"Front Genome Ed"},{"key":"769_CR13","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","volume":"27","author":"SG Deeks","year":"2021","unstructured":"Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong MAWP, et al. Research priorities for an HIV cure: international AIDS society global scientific strategy 2021. Nat Med. 2021;27:2085\u201398. https:\/\/doi.org\/10.1038\/s41591-021-01590-5.","journal-title":"Nat Med"},{"key":"769_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258096","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014. https:\/\/doi.org\/10.1126\/science.1258096.","journal-title":"Science"},{"key":"769_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.1225829","volume":"2012","author":"M Jinek","year":"1979","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 1979;2012:1\u20137. https:\/\/doi.org\/10.1126\/science.1225829.","journal-title":"Science"},{"key":"769_CR16","unstructured":"The Nobel Prize. The Nobel Prize in Chemistry 2020. (accessed May 26, 2024). https:\/\/www.nobelprize.org\/prizes\/chemistry\/2020\/popular-information\/"},{"key":"769_CR17","doi-asserted-by":"crossref","unstructured":"Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity One Sentence Summary. Science (1979) 2018;360:436\u20139.","DOI":"10.1126\/science.aar6245"},{"key":"769_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-022-00483-y","volume":"19","author":"R Bhowmik","year":"2022","unstructured":"Bhowmik R, Chaubey B. CRISPR\/Cas9: a tool to eradicate HIV-1. AIDS Res Ther. 2022;19:1\u201314. https:\/\/doi.org\/10.1186\/s12981-022-00483-y.","journal-title":"AIDS Res Ther"},{"key":"769_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JB.00580-17","volume":"200","author":"Y Ishino","year":"2018","unstructured":"Ishino Y, Krupovic M, Forterre P. History of CRISPR-Cas from encounter with a mysterious repeated sequence to genome editing technology. J Bacteriol. 2018;200:1\u201317. https:\/\/doi.org\/10.1128\/JB.00580-17.","journal-title":"J Bacteriol"},{"key":"769_CR20","doi-asserted-by":"publisher","unstructured":"Bialek JK, Walther T, Hauber J, Lange UC. CRISPR-cas9-based genome engineering to generate Jurkat reporter models for HIV-1 infection with selected proviral integration sites. J Visualized Experiments. 2018;141. https:\/\/doi.org\/10.3791\/58572.","DOI":"10.3791\/58572"},{"key":"769_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/v16020287","author":"U Hyder","year":"2024","unstructured":"Hyder U, Shukla A, Challa A, D\u2019Orso I. HIV-1 proviral genome engineering with CRISPR-Cas9 for mechanistic studies. Viruses. 2024. https:\/\/doi.org\/10.3390\/v16020287.","journal-title":"Viruses"},{"key":"769_CR22","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. 2021."},{"key":"769_CR23","doi-asserted-by":"publisher","unstructured":"Salimi-Jeda A, Esghaei M, Hossein keyvani, Bokharaei-Salim F, Teimoori A, Abdoli A. Inhibition of HIV-1 replication using the CRISPR\/cas9-no NLS system as a prophylactic strategy. Heliyon 2022;8. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10483","DOI":"10.1016\/j.heliyon.2022.e10483"},{"key":"769_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-023-02290-0","author":"N Ninyio","year":"2024","unstructured":"Ninyio N, Schmitt K, Sergon G, Nilsson C, Andersson S, Scherbak N. Stable expression of HIV-1 MPER extended epitope on the surface of the recombinant probiotic bacteria Escherichia coli Nissle 1917 using CRISPR\/Cas9. Microb Cell Fact. 2024. https:\/\/doi.org\/10.1186\/s12934-023-02290-0.","journal-title":"Microb Cell Fact"},{"key":"769_CR25","unstructured":"He Jiankui. About Lulu and Nana: Twin Girls Born Healthy After Gene Surgery As Single-Cell Embryos - YouTube. The He Lab 2018. https:\/\/www.youtube.com\/watch?v=th0vnOmFltc (accessed July 15, 2024)."},{"key":"769_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/d41586-018-07545-0","volume":"563","author":"David Cyranoski","year":"2018","unstructured":"Cyranoski David, Ledford Heidi. International outcry over genome-edited baby claim. Nature - News in Focus. 2018;563:607\u20138. https:\/\/doi.org\/10.1038\/d41586-018-07545-0","journal-title":"Nature - News in Focus"},{"key":"769_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08492-6","author":"X Li","year":"2023","unstructured":"Li X, Su B, Yang L, Kou Z, Wu H, Zhang T, et al. Highly sensitive and rapid point-of-care testing for HIV-1 infection based on CRISPR-Cas13a system. BMC Infect Dis. 2023. https:\/\/doi.org\/10.1186\/s12879-023-08492-6.","journal-title":"BMC Infect Dis"},{"key":"769_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2022.340303","author":"X Zhao","year":"2022","unstructured":"Zhao X, Tian X, Wang Y, Li L, Yu Y, Zhao S, et al. CRISPR-Cas12a-activated palindrome-catalytic hairpin assembly for ultrasensitive fluorescence detection of HIV-1 DNA. Anal Chim Acta. 2022. https:\/\/doi.org\/10.1016\/j.aca.2022.340303.","journal-title":"Anal Chim Acta"},{"key":"769_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2021.198505","author":"J Zhao","year":"2021","unstructured":"Zhao J, Ao C, Wan Z, Dzakah EE, Liang Y, Lin H, et al. A point-of-care rapid HIV-1 test using an isothermal recombinase-aided amplification and CRISPR Cas12a-mediated detection. Virus Res. 2021. https:\/\/doi.org\/10.1016\/j.virusres.2021.198505.","journal-title":"Virus Res"},{"key":"769_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2023.341258","author":"N Uno","year":"2023","unstructured":"Uno N, Li Z, Avery L, Sfeir MM, Liu C. CRISPR gel: a one-pot biosensing platform for rapid and sensitive detection of HIV viral RNA. Anal Chim Acta. 2023. https:\/\/doi.org\/10.1016\/j.aca.2023.341258.","journal-title":"Anal Chim Acta"},{"key":"769_CR31","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1021\/acsnano.2c12754","volume":"17","author":"Z Li","year":"2023","unstructured":"Li Z, Uno N, Ding X, Avery L, Banach D, Liu C. Bioinspired CRISPR-Mediated cascade reaction biosensor for molecular detection of HIV using a glucose meter. ACS Nano. 2023;17:3966\u201375. https:\/\/doi.org\/10.1021\/acsnano.2c12754.","journal-title":"ACS Nano"},{"key":"769_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.108713","author":"L Qin","year":"2023","unstructured":"Qin L, Lou F, Wang Y, Zhang Y, Liu S, Hun X. CRISPR\/Cas12a coupled with enzyme-DNA molecular switch photoelectrochemical assay for HIV nucleic acid. Microchem J. 2023. https:\/\/doi.org\/10.1016\/j.microc.2023.108713.","journal-title":"Microchem J"},{"key":"769_CR33","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1039\/d3lc00558e","volume":"23","author":"D Huang","year":"2023","unstructured":"Huang D, Zhao Y, Fang M, Shen P, Xu H, He Y, et al. Magnetofluid-integrated biosensors based on DNase-dead Cas12a for visual point-of-care testing of HIV-1 by an up and down chip. Lab Chip. 2023;23:4265\u201375. https:\/\/doi.org\/10.1039\/d3lc00558e.","journal-title":"Lab Chip"},{"key":"769_CR34","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1039\/d2cc00792d","volume":"58","author":"J Zhou","year":"2022","unstructured":"Zhou J, Hu J, Liu R, Wang C, Lv Y. Dual-amplified CRISPR-Cas12a bioassay for HIV-related nucleic acids. Chem Commun. 2022;58:4247\u201350. https:\/\/doi.org\/10.1039\/d2cc00792d.","journal-title":"Chem Commun"},{"key":"769_CR35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1021\/acssensors.0c00497","volume":"5","author":"R Nouri","year":"2020","unstructured":"Nouri R, Jiang Y, Lian XL, Guan W. Sequence-specific recognition of HIV-1 DNA with Solid-State CRISPR-Cas12a-Assisted nanopores (SCAN). ACS Sens. 2020;5:1273\u201380. https:\/\/doi.org\/10.1021\/acssensors.0c00497.","journal-title":"ACS Sens"},{"key":"769_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.690647","author":"R Elangovan","year":"2021","unstructured":"Elangovan R, Jenks M, Yun J, Dickson-Tetteh L, Kirtley S, Hemelaar J. Global and regional estimates for subtype-specific therapeutic and prophylactic HIV-1 vaccines: a modeling study. Front Microbiol. 2021. https:\/\/doi.org\/10.3389\/fmicb.2021.690647.","journal-title":"Front Microbiol"},{"key":"769_CR37","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1016\/j.csbj.2023.09.005","volume":"21","author":"B Deng","year":"2023","unstructured":"Deng B, Xue J. HIV infection detection using CRISPR\/Cas systems: present and future prospects. Comput Struct Biotechnol J. 2023;21:4409\u201323. https:\/\/doi.org\/10.1016\/j.csbj.2023.09.005.","journal-title":"Comput Struct Biotechnol J"},{"key":"769_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002251","author":"JM Cuevas","year":"2015","unstructured":"Cuevas JM, Geller R, Garijo R, L\u00f3pez-Aldeguer J, Sanju\u00e1n R. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol. 2015. https:\/\/doi.org\/10.1371\/journal.pbio.1002251.","journal-title":"PLoS Biol"},{"key":"769_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18575-6","author":"X Ding","year":"2020","unstructured":"Ding X, Yin K, Li Z, Lalla RV, Ballesteros E, Sfeir MM, et al. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-18575-6.","journal-title":"Nat Commun"},{"key":"769_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2217\/fvl.12.37","volume":"7","author":"A Huang","year":"2012","unstructured":"Huang A, Hogan JW, Istrail S, Delong A, Katzenstein DA, Kantor R. Global analysis of sequence diversity within HIV-1 subtypes across geographic regions. Future Virol. 2012;7:505\u201317. https:\/\/doi.org\/10.2217\/fvl.12.37.","journal-title":"Future Virol"},{"key":"769_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181943","author":"MK Rahman","year":"2017","unstructured":"Rahman MK, Rahman MS. CRISPRpred: a flexible and efficient tool for sgRNAs on-target activity prediction in CRISPR\/Cas9 systems. PLoS One. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0181943.","journal-title":"PLoS One"},{"key":"769_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, et al. Optimized SgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34:184\u201391. https:\/\/doi.org\/10.1038\/nbt.3437.","journal-title":"Nat Biotechnol"},{"key":"769_CR43","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet JP, Haeussler M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 2018;46:W242\u20135. https:\/\/doi.org\/10.1093\/nar\/gky354.","journal-title":"Nucleic Acids Res"},{"key":"769_CR44","doi-asserted-by":"publisher","first-page":"10701","DOI":"10.1021\/acsnano.3c01917","volume":"17","author":"R Nouri","year":"2023","unstructured":"Nouri R, Jiang Y, Politza AJ, Liu T, Greene WH, Zhu Y, et al. STAMP-based digital CRISPR-Cas13a for amplification-free quantification of HIV-1 plasma viral loads. ACS Nano. 2023;17:10701\u201312. https:\/\/doi.org\/10.1021\/acsnano.3c01917.","journal-title":"ACS Nano"},{"key":"769_CR45","doi-asserted-by":"publisher","DOI":"10.1109\/SENSORS52175.2022.9967104","author":"R Nouri","year":"2022","unstructured":"Nouri R, Jiang Y, Politza AJ, Lian XL, Guan W. Digital CRISPR-based quantification of HIV-1. IEEE Sens. 2022. https:\/\/doi.org\/10.1109\/SENSORS52175.2022.9967104.","journal-title":"IEEE Sens"},{"key":"769_CR46","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nm.4108","volume":"22","author":"SG Deeks","year":"2016","unstructured":"Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, et al. International AIDS society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016;22:839\u201350. https:\/\/doi.org\/10.1038\/nm.4108.","journal-title":"Nat Med"},{"key":"769_CR47","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3262","volume":"12","author":"SG Deeks","year":"2012","unstructured":"Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012;12:607\u201314. https:\/\/doi.org\/10.1038\/nri3262.","journal-title":"Nat Rev Immunol"},{"key":"769_CR48","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20190287","author":"H Hartweger","year":"2019","unstructured":"Hartweger H, McGuire AT, Horning M, Taylor JJ, Dosenovic P, Yost D, et al. HIV-specific humoral immune responses by CRISPR\/Cas9-edited B cells. J Exp Med. 2019. https:\/\/doi.org\/10.1084\/JEM.20190287.","journal-title":"J Exp Med"},{"key":"769_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/v13091850","author":"H Nguyen","year":"2021","unstructured":"Nguyen H, Wilson H, Jayakumar S, Kulkarni V, Kulkarni S. Efficient inhibition of HIV using CRISPR\/Cas13d nuclease system. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13091850.","journal-title":"Viruses"},{"key":"769_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115046","author":"M Fan","year":"2023","unstructured":"Fan M, Bao Y, Berkhout B, Herrera-Carrillo E. CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures. Biomed Pharmacother. 2023. https:\/\/doi.org\/10.1016\/j.biopha.2023.115046.","journal-title":"Biomed Pharmacother"},{"key":"769_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/v12111223","author":"Y Ophinni","year":"2020","unstructured":"Ophinni Y, Miki S, Hayashi Y, Kameoka M. Multiplexed tat-targeting CRISPR-Cas9 protects t cells from acute HIV-1 infection with inhibition of viral escape. Viruses. 2020. https:\/\/doi.org\/10.3390\/v12111223.","journal-title":"Viruses"},{"key":"769_CR52","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41434-023-00413-1","volume":"31","author":"S Klinnert","year":"2024","unstructured":"Klinnert S, Schenkel CD, Freitag PC, G\u00fcnthard HF, Pl\u00fcckthun A, Metzner KJ. Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery. Gene Ther. 2024;31:74\u201384. https:\/\/doi.org\/10.1038\/s41434-023-00413-1.","journal-title":"Gene Ther"},{"key":"769_CR53","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/mt.2016.7","volume":"24","author":"H Ji","year":"2016","unstructured":"Ji H, Jiang Z, Lu P, Ma L, Li C, Pan H, et al. Specific reactivation of latent HIV-1 by dCas9-SunTag-VP64-mediated guide RNA targeting the HIV-1 promoter. Mol Ther. 2016;24:508\u201321. https:\/\/doi.org\/10.1038\/mt.2016.7.","journal-title":"Mol Ther"},{"key":"769_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep16277","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Yin C, Zhang T, Li F, Yang W, Kaminski R, et al. CRISPR\/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs. Nature - Scientific Reports. 2015. https:\/\/doi.org\/10.1038\/srep16277.","journal-title":"Nature - Scientific Reports"},{"key":"769_CR55","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/mt.2015.213","volume":"24","author":"P Limsirichai","year":"2016","unstructured":"Limsirichai P, Gaj T, Schaffer DV. CRISPR-mediated activation of latent HIV-1 expression. Am Soc Gene Cell Therapy. 2016;24:499\u2013507. https:\/\/doi.org\/10.1038\/mt.2015.213.","journal-title":"Am Soc Gene Cell Therapy"},{"key":"769_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/mt.2015.202","volume":"24","author":"SM Saayman","year":"2016","unstructured":"Saayman SM, Lazar DC, Scott TA, Hart JR, Takahashi M, Burnett JC, et al. Potent and targeted activation of latent HIV-1 using the CRISPR\/dCas9 activator complex. Mol Ther. 2016;24:488\u201398. https:\/\/doi.org\/10.1038\/mt.2015.202.","journal-title":"Mol Ther"},{"key":"769_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158294","author":"JK Bialek","year":"2016","unstructured":"Bialek JK, Dunay GA, Voges M, Sch\u00e4fer C, Spohn M, Stucka R, et al. Targeted HIV-1 latency reversal using CRISPR\/Cas9-derived transcriptional activator systems. PLoS One. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0158294.","journal-title":"PLoS One"},{"key":"769_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/srep31527","author":"R Kaminski","year":"2016","unstructured":"Kaminski R, Chen Y, Salkind J, Bella R, Young W Bin, Ferrante P, et al. Negative feedback regulation of HIV-1 by gene editing strategy. Nature - Scientific Reports. 2016. https:\/\/doi.org\/10.1038\/srep31527.","journal-title":"Nature - Scientific Reports"},{"key":"769_CR59","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41434-023-00410-4","volume":"31","author":"TH Burdo","year":"2023","unstructured":"Burdo TH, Chen C, Kaminski R, Sariyer IK, Mancuso P, Donadoni M, et al. Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates. Gene Ther. 2023;31:224\u201333. https:\/\/doi.org\/10.1038\/s41434-023-00410-4.","journal-title":"Gene Ther"},{"key":"769_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep22555","author":"R Kaminski","year":"2016","unstructured":"Kaminski R, Chen Y, Fischer T, Tedaldi E, Napoli A, Zhang Y, et al. Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR\/Cas9 gene editing. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep22555.","journal-title":"Sci Rep"},{"key":"769_CR61","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","volume":"25","author":"C Yin","year":"2017","unstructured":"Yin C, Zhang T, Qu X, Zhang Y, Putatunda R, Xiao X, et al. In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models. Mol Ther. 2017;25:1168\u201386. https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.012.","journal-title":"Mol Ther"},{"key":"769_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.omtn.2018.05.021","volume":"12","author":"R Bella","year":"2018","unstructured":"Bella R, Kaminski R, Mancuso P, Young W Bin, Chen C, Sariyer R, et al. Removal of HIV DNA by CRISPR from patient blood engrafts in humanized mice. Mol Ther Nucleic Acids. 2018;12:275\u201382. https:\/\/doi.org\/10.1016\/j.omtn.2018.05.021.","journal-title":"Mol Ther Nucleic Acids"},{"key":"769_CR63","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/gt.2016.41","volume":"23","author":"R Kaminski","year":"2016","unstructured":"Kaminski R, Bella R, Yin C, Otte J, Ferrante P, Gendelman HE, et al. Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study. Gene Ther. 2016;23:690\u20135. https:\/\/doi.org\/10.1038\/gt.2016.41.","journal-title":"Gene Ther"},{"key":"769_CR64","unstructured":"Excision BioTherapeutics. Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART (NCT05144386) - Study details. ClinicalTrialsGov 2024. https:\/\/clinicaltrials.gov\/study\/NCT05144386?cond=HIV&intr=crispr&rank=2&a=14 (accessed August 2, 2024)."},{"key":"769_CR65","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","volume":"25","author":"L Xu","year":"2017","unstructured":"Xu L, Yang H, Gao Y, Chen Z, Xie L, Liu Y, et al. CRISPR\/Cas9-mediated CCR5 ablation in human hematopoietic stem\/progenitor cells confers HIV-1 resistance in vivo. Mol Ther. 2017;25:1782\u20139. https:\/\/doi.org\/10.1016\/j.ymthe.2017.04.027.","journal-title":"Mol Ther"},{"key":"769_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.821190","author":"SH Scheller","year":"2022","unstructured":"Scheller SH, Rashad Y, Saleh FM, Willingham KA, Reilich A, Lin D, et al. Biallelic, selectable, knock-in targeting of CCR5 via CRISPR-Cas9 mediated homology directed repair inhibits HIV-1 replication. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.821190.","journal-title":"Front Immunol"},{"key":"769_CR67","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1099\/vir.0.000139","volume":"96","author":"C Li","year":"2015","unstructured":"Li C, Guan X, Du T, Jin W, Wu B, Liu Y, et al. Inhibition of HIV-1 infection of primary CD4\u2009+\u2009T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9. J Gen Virol. 2015;96:2381\u201393. https:\/\/doi.org\/10.1099\/vir.0.000139.","journal-title":"J Gen Virol"},{"key":"769_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115987","author":"W Wang","year":"2014","unstructured":"Wang W, Ye C, Liu J, Zhang D, Kimata JT, Zhou P. CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection. PLoS One. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0115987.","journal-title":"PLoS One"},{"key":"769_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.42","author":"HJ Kang","year":"2015","unstructured":"Kang HJ, Minder P, Park MA, Mesquitta WT, Torbett BE, Slukvin II. CCR5 disruption in induced pluripotent stem cells using CRISPR\/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus. Mol Ther Nucleic Acids. 2015. https:\/\/doi.org\/10.1038\/mtna.2015.42.","journal-title":"Mol Ther Nucleic Acids"},{"key":"769_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/srep15577","author":"P Hou","year":"2015","unstructured":"Hou P, Chen S, Wang S, Yu X, Chen Y, Jiang M, et al. Genome editing of CXCR4 by CRISPR\/cas9 confers cells resistant to HIV-1 infection. Sci Rep. 2015. https:\/\/doi.org\/10.1038\/srep15577.","journal-title":"Sci Rep"},{"key":"769_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-017-0375-0","author":"Q Wang","year":"2017","unstructured":"Wang Q, Chen S, Xiao Q, Liu Z, Liu S, Hou P, et al. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection. Retrovirology. 2017. https:\/\/doi.org\/10.1186\/s12977-017-0375-0.","journal-title":"Retrovirology"},{"key":"769_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26894-4","author":"S Liu","year":"2018","unstructured":"Liu S, Wang Q, Yu X, Li Y, Guo Y, Liu Z, et al. HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-26894-4.","journal-title":"Sci Rep"},{"key":"769_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/hum.2017.032","volume":"29","author":"S Yu","year":"2018","unstructured":"Yu S, Yao Y, Xiao H, Li J, Liu Q, Yang Y, et al. Simultaneous knockout of CXCR4 and CCR5 genes in CD4\u2009+\u2009T cells via CRISPR\/Cas9 confers resistance to both X4- and R5-tropic human immunodeficiency virus type 1 infection. Hum Gene Ther. 2018;29:51\u201367. https:\/\/doi.org\/10.1089\/hum.2017.032.","journal-title":"Hum Gene Ther"},{"key":"769_CR74","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.omtm.2022.01.012","volume":"24","author":"S Li","year":"2022","unstructured":"Li S, Holguin L, Burnett JC. CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice. Mol Ther Methods Clin Dev. 2022;24:321\u201331. https:\/\/doi.org\/10.1016\/j.omtm.2022.01.012.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"769_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-017-0174-2","author":"Z Liu","year":"2017","unstructured":"Liu Z, Chen S, Jin X, Wang Q, Yang K, Li C, et al. Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4\u2009+\u2009T cells from HIV-1 infection. Cell Biosci. 2017. https:\/\/doi.org\/10.1186\/s13578-017-0174-2.","journal-title":"Cell Biosci"},{"key":"769_CR76","unstructured":"Safety of Transplantation of CRISPR CCR5 Modified CD34\u2009+\u2009Cells in HIV-infected Subjects With Hematological Malignances - Study Details. ClinicalTrialsGov n.d. https:\/\/clinicaltrials.gov\/study\/NCT03164135?cond=HIV&term=crispr&rank=1 (accessed August 15, 2024)."},{"key":"769_CR77","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMOA1817426","volume":"381","author":"L Xu","year":"2019","unstructured":"Xu L, Wang J, Liu Y, Xie L, Su B, Mou D, et al. CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia. N Engl J Med. 2019;381:1240\u20137. https:\/\/doi.org\/10.1056\/NEJMOA1817426.","journal-title":"N Engl J Med"},{"key":"769_CR78","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.tibtech.2020.10.010","volume":"39","author":"CMA Zeballos","year":"2021","unstructured":"Zeballos CMA, Gaj T. Next-generation CRISPR technologies and their applications in gene and cell therapy. Trends Biotechnol. 2021;39:692\u2013705. https:\/\/doi.org\/10.1016\/j.tibtech.2020.10.010.","journal-title":"Trends Biotechnol"},{"key":"769_CR79","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.tibtech.2023.03.004","volume":"41","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Shang P, Mohanraju P, Geijsen N. Prime editing: advances and therapeutic applications. Trends Biotechnol. 2023;41:1000\u201312. https:\/\/doi.org\/10.1016\/j.tibtech.2023.03.004.","journal-title":"Trends Biotechnol"},{"issue":"3","key":"769_CR80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","volume":"24","author":"PJ Chen","year":"2022","unstructured":"Chen PJ, Liu DR. Prime editing for precise and highly versatile genome manipulation. Nat Rev Genet. 2022;24(3):161\u201377. https:\/\/doi.org\/10.1038\/s41576-022-00541-1.","journal-title":"Nat Rev Genet"},{"key":"769_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15053-x","author":"NS McCarty","year":"2020","unstructured":"McCarty NS, Graham AE, Studen\u00e1 L, Ledesma-Amaro R. Multiplexed CRISPR technologies for gene editing and transcriptional regulation. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-15053-x.","journal-title":"Nat Commun"},{"key":"769_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/cells14151136","author":"MA Rauf","year":"2025","unstructured":"Rauf MA, Rao A, Sivasoorian SS, Iyer AK. Nanotechnology-based delivery of CRISPR\/Cas9 for cancer treatment: a comprehensive review. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14151136.","journal-title":"Cells"},{"key":"769_CR83","doi-asserted-by":"publisher","unstructured":"Vats P, Baweja B, Saini C, Singh Kushwah A, Kumar A, Srivastava SK et al. An overview of CRISPR-artificial intelligence theranostics: current and emerging applications n.d.:2025. https:\/\/doi.org\/10.12336\/bmt.25.00106","DOI":"10.12336\/bmt.25.00106"},{"key":"769_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1226182","author":"M Lee","year":"2023","unstructured":"Lee M. Deep learning in CRISPR-Cas systems: a review of recent studies. Front Bioeng Biotechnol. 2023. https:\/\/doi.org\/10.3389\/fbioe.2023.1226182.","journal-title":"Front Bioeng Biotechnol"},{"key":"769_CR85","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s12276-025-01462-9","volume":"57","author":"MG Kim","year":"2025","unstructured":"Kim MG, Go MJ, Kang SH, Jeong SH, Lim K. Revolutionizing CRISPR technology with artificial intelligence. Exp Mol Med. 2025;57:1419\u201331. https:\/\/doi.org\/10.1038\/s12276-025-01462-9.","journal-title":"Exp Mol Med"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00769-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00769-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00769-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:24:58Z","timestamp":1768472698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00769-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00769-6","relation":{},"ISSN":["1548-3576"],"issn-type":[{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}